Skip to search formSkip to main contentSkip to account menu

Trimetazidine

Known as: 1-[2,3,4-trimethoxybenzyl] piperazine dihydrochloride, Piperazine, 1-((2,3,4-trimethoxyphenyl)methyl)-, Trimetazidine [Chemical/Ingredient] 
A vasodilator used in angina of effort or ischemic heart disease.
National Institutes of Health

Related topics

Related topics

12 relations

Narrower (4)

IdaptanS 35171Trimetazidine DihydrochlorideVastarel
In Bloodagonistsanalogs & derivativesantagonists & inhibitors

Broader (1)

Vasodilator Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Suppression of arsenic trioxide-induced apoptosis in HeLa cells by N-acetylcysteine.
2008
2008
Intracellular GSH levels rather than ROS levels are tightly related to AMA-induced HeLa cell death.
2004
2004
Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the Trimpol II study
SUMMARY Objectives: The revascularization procedures become more and more popular to treat coronary artery disease, in many… 
2004
2004
Effects of Trimetazidine on Left Ventricular Function in Patients with Type 2 Diabetes and Heart Failure
Congestive heart failure and type 2 diabetes have a deleterious prognosis when combined. Trimetazidine, a metabolic agent with… 
2002
2002
Last performance with VIAGRA: post-mortem identification of sildenafil and its metabolites in biological specimens including hair sample.
2002
2002
OXIDATIVE STRESS-MEDIATED RENAL DYSFUNCTION BY CYCLOSPORINE A IN RATS: ATTENUATION BY TRIMETAZIDINE
Cyclosporine A (CsA) is one of the first line immunosuppressants employed in the management of solid organ transplantation and… 
Review
2002
Review
2002
The Use of Partial Fatty Acid Oxidation Inhibitors for Metabolic Therapy of Angina Pectoris and Heart Failure
Background: Partial fatty acid oxidation inhibitors have raised great interest since they are expected to counteract a… 
1999
1999
Effects of Trimetazidine Administration before Thrombolysis in Patients with Anterior Myocardial Infarction: Short-term and Long-term Results
Reperfusion may prevent or reduce the development and extent of necrosis, but may also lead to an increase in reperfusion damage… 
1998
1998
Coronary artery constriction in rats: necrotic and apoptotic myocyte death.
1997
1997
Trimetazidine increases phosppholipid turnover in ventricular myocyte
Trimetazidine (TMZ) is an anti-ischemic compound devoid of hemodynamic effects. It was recently suggested to induce cardiomyocyte… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)